A Promising Future for Marine Drugs and Natural Products

Natural products, although a valuable and precious resource, also come with their fair share of challenges in a variety of aspects. As mentioned before, one of the major issues concerning the use of natural products are the difficulties associated with obtaining sufficient amounts of material pure enough for discovery and development activities. If a compound is derived from a plant growing only in small quantities or remote locations or a marine organisms residing in great depth or difficult to access regions, Ayurveda medicine  re-supply becomes a problem. The threat of losing potentially valuable natural sources of pharmacologically active ingredients is constantly increasing due to the threat of extinction by deforestation of large landmasses and environmental pollution in remote areas as well as global warming. It is estimated that about 70% of the supply of herbal raw material other homeopathic medicine in India comes from the wild. To meet the increasing demand for raw material, to conserve wild resources, and to reduce the potential variability in the active ingredient content in medicinal plants from different collection areas, it is important to implement more controlled cultivation programs to ensure quality and to protect resources 

Natural product screening remains one of the most useful avenues for bioactive discovery. In the past decades, studies on MNP have been focused mainly on macroorganisms, i.e., sponges, corals and other marine invertebrates, although significant developments have been made in the microorganisms area. However, despite the large number of NCEs isolated from marine organisms, many of them with pronounced biological activity, the great majority does not surpass the pharmaceutical pre-clinical trials and only a very few have been marketed as pharmaceutical products. Besides the usual drawbacks in any drug discovery process, the industrial development of many promising MNP was hampered by additional difficulties such as sustainable source and issues related to structural complexity and scale up. Nevertheless, the global marine pharmaceutical pipeline remains very active and includes, at the moment, eight Food and Drug Administration (FDA) or European Medicines Agency (EMEA) approved drugs and several compounds in different phases of the clinical pipeline.

  • Improved bioavailability
  • Relevant mechanisms of action
  • Most potent inhibitors
  • Less unwanted side effects
  • Potential drug targets encoded by human genome
  • Innovations in marine natural products research

Related Conference of A Promising Future for Marine Drugs and Natural Products

January 21-22, 2019 |

14th Annual Meet on Euro Ethnopharmacology

Amsterdam, Netherlands
January 28-29, 2019

12th World Congress on Future Pharma

Paris, France
January 30-31, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Courtyard Marriott Seoul Times Square | Seoul, South Korea
January 31-February 01, 2019

9th World Congress on Chromatography

Paris | France
February 20-21, 2019

World Congress on Drug Discovery and Drug Design

Singapore
February 22-23, 2019 |

13th World Drug Delivery Summit

San Francisco, USA
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
March 27-28, 2019

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
April 04-06, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Auckland, NewZealand
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
April 17-18, 2019

International Conference on Global Analytica

Osaka, Japan

April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
April 22-23, 2019

5th Annual Congress on Clinical & Hospital Pharmacy

| Radisson Narita | Tokyo, Japan
May 06-07, 2019

6th World Congress on Advanced Clinical Trials and Clinical Research

| Novotel | Brisbane, Australia
May 06-07, 2019

2nd Annual Pharmaceutical Biotechnology Congress

Radisson Narita | Tokyo, Japan
May 6-7, 2019

11th World Congress on Neuropharmacology

Prague, Czech Republic
May 20-21, 2019

7th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance

Radisson Hotel Narita | Tokyo, Japan
May 20-22, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
March 22-23, 2019

5th International Conference on Antibiotics

Orlando, USA
June 17-18, 2019

7th European Biopharma Congress

Stockholm, Sweden
June 17-18, 2019

14th World Congress on Pharmacology and Drug Safety

Lisbon, Portugal
June 27-28, 2019

18th Annual Congress on Pharmaceutics & Drug Delivery Systems

Amsterdam, Netherlands
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA

August 19-20, 2019

24th World Congress on Pharmacology

Vienna, Austria
September 11-12, 2019

14th World Congress on Pharmacology and Toxicology

Holiday Inn Atrium | Singapore
September 18-19, 2019

6th World Congress on Natural Products, Medicinal Plants and Traditional Medicines

| Radisson Narita | Tokyo, Japan
November 11-12, 2019

20th Annual Pharma Middle East Congress

Istanbul, Turkey

A Promising Future for Marine Drugs and Natural Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in